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ABSTRACT 
 
Introduction:  Neisseria gonorrhoeae and HIV are major public health concerns globally.  The 
interaction between these diseases is unclear.  To determine the effect that N. gonorrhoeae and HIV 
have on the tight junctions of cervical epithelial cells, a cervical epithelial cell line was infected 
with N. gonorrhoeae only, HIV only and with N. gonorrhoeae and HIV simultaneously.   
 
Methods:  The ME180 cervical cell line was grown to confluence and infected withN. gonorrhoeae 
only, HIV only and with N. gonorrhoeae and HIV simultaneously.  Following infection, N. 
gonorrhoeae and HIV tansmigration assays and the blue dextran permeability assay were also 
performedto determine the effect that exposure to the microbes would have on the intact cervical 
epithelial layer.  The tight junction gene expression assays, blue dextran permeability assay and 
immunofluorescence staining was performed to determine the effect that exposure to the different 
microbes had on the tight junctions.   
 
Results:   The results of this study showed that exposure of the cervical epithelial layer to N. 
gonorrhoeae alone, HIV alone and to N. gonorrhoeae and HIV simultaneously did not affect the 
paracellular permeability of the epithelial layer.  The results showed that a small percentage of 
N.gonorrhoeaeand HIV was able to migrate across the epithelial layer.  With the simultaneous 
infection of N.gonorrhoeae and HIV, the presence of HIV did not seem to influence the migration 
of N. gonorrhoeae, as compared to infection with N. gonorrhoeae only, while the presence of 
N.gonorrhoeae seemed to cause the HIV to pass through the epithelial layer less efficiently than 
with exposure to HIV only.   
 
Discussion:  The overall results suggest that since exposure to these microbes does not seem to 
affect the tight junctions of the intact epithelial layer and does not affect the paracellular 
permeability, the migration of the microbes across the epithelial layer was possibly through 
transcytosis. 
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CHAPTER 1: INTRODUCTION 
 
The aetiological agent of gonorrhoea is the obligate human pathogen Neisseria gonorrhoeae.   
Epidemiological data have shown that gonorrhoea is still a major public health concern globally, as 
approximately 78 million new cases of gonorrhoea were reported for 2017 (WHO 2019).  Another 
major global public health concern is infection with Human Immunodeficiency Virus (HIV).  The 2018 
United Nations Programme on HIV/AIDS (UNAIDS) report estimated that in 2017 about 36.9 million 
of the global populationwere infected with HIV, with approximately 1.8 million cases occurring in that 
year (UNAIDS 2018).  In South Africa, these two diseases pose a huge public health threat.  
Gonorrhoea and HIV are both sexually transmitted diseases (STDs).  A strong associationbetween STDs 
and HIV have been observed, however, the interaction between these diseases is unclear.  Research has 
attempted to elucidate the relationship between gonorrhoea and HIV.  Studies have suggested that a 
bidirectional relationship exists between STDs and HIV (Chun et al. 2013).  While some studies have 
suggested that STDs increase the risk of acquiring HIV, other studies have suggested the converse. 
 
An intact epithelial layer should serve as an effective barrier against pathogenic microbes.  However, 
studies have shown that HIV-1 could migrate across an intact epithelial layer and lead to infection.  HIV 
usually enters host cells by binding to the CD4 receptors on the host cells.  However, the genital 
epithelial cells do not express these receptors, which suggests that HIV-1 would not be able to enter 
these cells through the usual route of entry.  Studies have suggested that HIV-1 can enter epithelial cells 
through endocytosis, which involves transporting macromolecules within vesicles across a cell.  
Transcytosis of HIV-1 was reported by Kinlock et al. (2014), when they showed that HIV-1 could be 
transported across the cell via the endocytic recycling pathway.  Interestingly, they showed that 
endocytosed native virus successfully transcytosed through the cell, whereas the endocytosed heat-
inactivated HIV-1 was processed through the degradation pathway (Kinlock et al. 2014). 
 
An alternate mechanism of HIV-1 movement across the epithelial layer was suggested by other studies. 
One study suggested that exposure of epithelial cells to HIV resulted in the disruption of the tight 
junctions of the cells, which enabled microbial entry via the paracellular route (Nazli et al. 2010).  This 
was also demonstrated inanother study which showed that exposure of oral epithelial cells to HIV-1 
caused disruption to the tight junctions, thereby enabling human papillomavirus to move across the 
epithelial layer (S. M. Tugizov et al. 2013).  Furthermore, a different study showed that HIV exposure 
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caused disruption to both the tight and adherens junction proteins and facilitated  paracellular movement 
of HSV-1 across the epithelial layer, as well as enabling cell to cell movement of HSV-1(Sufiawati and 
Tugizov 2014). 
 
This study aimed to determine the effect that infection with N.gonorrhoeae only, HIV only and N. 
gonorrhoeae and HIV simultaneously would have on the tight junction of cervical epithelial cells.    The 
hypothesis was that HIV would cause disruption to the tight junctions, thereby enabling N. gonorrhoeae 
together with HIV to cross the epithelial layer by means of the paracellular pathway.   
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CHAPTER 2: LITERATURE REVIEW 
 
2.1 Neisseria gonorrhoeae 
 
2.1.1 Historical Background and Characteristics 
Gonorrhoea was first described approximately 3500 years ago, making it one of the oldest 
diseases identified by man (J. L. Edwards and Apicella 2004; Hill et al. 2016).  Galen (130 -
200 AD) named the disease proposing a name derived from the Greek words “gonos” 
meaning semen and “rhoia” meaning to flow, when he mistakenly identified the gonococcal 
discharge as “an unwanted secretion of semen without erection” (Oriel 1996).  It was not 
until 1879 that the causative agent of this disease, Neisseria gonorrhoeae was discovered 
microscopically by Albert Ludwig Sigesmund Neisser (Ligon 2005).  However, the 
organism was only cultivated in 1882 by Leistikow and Löffler (J. L. Edwards and Apicella 
2004).  N. gonorrhoeae is a gram-negative diplococcus of which the individual cells have 
flattened adjacent sides, giving it the appearance of a kidney or coffee bean.  They are non-
motile, non-sporulating and are aerobic organisms that grow well at 37°C in a moistened 
atmosphere that contains 3 to 5% CO2 (Carr 2017).  N. gonorrhoeae is an obligate human 
pathogen and the initial site of infection in men is the urethra and in women the endocervix 
and urethra (J. L. Edwards and Apicella 2004; Stevens and Criss 2018).  The organism can 
also infect otherepithelialsurfaces, including the pharynx, conjunctiva and the rectum (Hill 
et al. 2016).  N.gonorrhoeae has virulence factors that enhance its pathogenicity.  These 
factors include the capsule (which helps to avoid phagocytosis), pili (which allows the 
organism to attach to cell surfaces) and lipooligosaccharide (LOS), which is a variant of 
lipopolysaccharide (LPS)and IgA-protease that cleaves immunoglobulin A (IgA) (Carr 
2017).  Both LOS and LPS contain lipid-A which is the main endotoxic component of these 
lipid-carbohydrate compounds.   
 
2.1.2 Epidemiology 
Neisseria gonorrhoeae infections are a major global health concern.  According to the2019 
World Health Organization (WHO) fact sheet, it is estimated that there were approximately 
357 million new cases of the four curable sexually transmitted infections (STIs), i.e 
gonorrhoea, chlamydia infection, syphilis and trichomoniasis, occurring globally.  
Approximately 78 million of these cases were attributed to gonorrhoea (WHO 2019).  In 
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South Africa, STIs continue to be a major public health problem.  In 2017, the prevalence 
of gonorrhoea in this country was approximately 6.6% (3.8 – 10.8%) in females and 3.5% 
(1.7 – 6.1%) in males.  The estimated incidence of gonorrhoea in South Africa in 2017 was 
approximately 2.3 (1.1 – 5.0) million cases in women and 2.2 (1.1 – 3.0) million cases in 
males (Kularatne et al. 2018). 
 
2.1.3 Transmission and Clinical Manifestations 
Gonorrhoea is a sexually transmitted disease that can be transmitted from an infected 
partner during vaginal, oral or anal sex.   However, the disease can also be spread from an 
infected mother to her child during delivery.  Neisseria gonorrhoeae is transmitted more 
efficiently to females from their infected male partners than from infected females to their 
male partners.  This could be due to differences in the anatomy of the male and female 
genitalia, which allows the organism to have a longer period of contact with the female 
genital membranes following sex.  The clinical manifestations of the disease depend on the 
site of infection (J. L. Edwards and Apicella 2004).  The symptoms of gonococcal infection 
in females include vaginal discharge, dysuria,lower abdominal pain, rectal pain and 
abnormal uterine bleeding.  In males, the symptoms include urethral discharge, dysuria and 
pain in the testicles or rectum.  If the gonococcal infection is left untreated, women may 
experience pelvic inflammatory disease, chronic pelvic pain and tubal infertility, while men 
may present with epidydimitis, prostatitis, urethral stricture and rarely with infertility (Diez 
and Diaz 2011; Lenz and Dillard 2018; Ng and Martin 2005; Piszczek et al. 2015).  
Neonates that contract gonorrhoea during delivery present with neonatal conjunctivitis 
(ophthalmia neonatorum).  If the conjunctivitis is left untreated, it can cause scarring and 
blindness (Alirol et al. 2017). 
 
2.1.4 Diagnosis 
Neisseria gonorrhoeae can be diagnosed in the laboratory through presumptive and 
confirmation tests.  The presumptive tests include Gram staining and culturing the organism 
on selective media followed by the oxidase test, the catalase test and the colistin resistance 
test.  The organism produces a positive reaction in the oxidase, catalase tests and is resistant 
to colistin.  The confirmation tests include biochemical tests, serological tests and nucleic 
acid amplification tests (NAATs) (Ng and Martin 2005).  The Gram stain and culture 
method were the initial diagnostic tests used for gonorrhoea until the late 1980s.  The Gram 
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stain involves firstly collecting a swab sample from either the cervix, urethra, rectum or 
vagina.  The swab is then rolled carefully over an area of a microscope slide, heat-fixed and 
stained using the Gram stain procedure, which includes staining the smear with crystal 
violet (i.e a primary stain), then applying iodine (a mordant), followed by decolourisation 
with ethanol and finally by staining with a counterstain eg. diluted carbolfuschin.  The slide 
is then viewed under the microscope using an oil immersion objective.  Gram-positive cells 
are seen as purple cells (as they have thicker peptidogylcan walls and retain the crystal 
violet stain) and gram-negative cells are seen as pink cells (as they have a thinner 
peptidyglycan layer, which results in the alcohol decolorising the cell thereby allowing the 
cells to be counterstained with carbolfuschin).  The Gram stain is a rapid method of 
detection with a sensitivityof +95% in males with visible discharge. This is comparable to 
culture for symptomatic urethral gonorrhoea in this group.  However, there is decreased 
sensitivity for specimens collected from females (i.e 40-60%), as well as in males for 
specimens other than urethral swabs and in non-symptomatic males or males with dysuria 
only.  For those the sensitivity of microscopy is very low and thus not recommended.  
Bacterial culture involves inoculating the specimen onto a medium that supports the growth 
of N. gonorrhoeae like New York City agar, Thayer Martin agar or chocolate agar 
containing antimicrobials that do not inhibit the growth of N. gonorrhoeae, while 
preventing the growth of contaminating bacteria and fungi.  The media are incubated at 35-
37°C in a moistened environment containing CO2 (4 – 6%). Bacterial culture is considered 
the gold standard for diagnosing gonorrhoea with a sensitivity of 85 – 95% and a specificity 
of up to 100% (Meyer and Buder 2020; Muralidhar 2015).  The other advantages of using 
bacterial culture is the relatively low cost and that it produces viable organisms that can be 
used for testing for antimicrobial susceptibility.  The disadvantage of this method is that it 
requires the collection of an invasive specimen that must be transported under stringent 
conditions to ensure that the organism remains viable.  Nucleic acid amplification tests, for 
the detection of gonorrhoea, were introduced for routine use in the early 1990s.  Nucleic 
acid amplification tests are used to detect N. gonorrhoeae nucleic acid using polymerase 
chain reaction.  Several FDA-approved commercial kits are available, including Abbott 
RealTime CT/NG (Abbott, Des Plaines, USA), cobas CT/NG (Roche Diagnostics, 
Indianopolis, USA) and Aptima Combo2 Assay (Hologic, San Diego, USA).The 
advantages of NAATs over bacterial culture is that the sensitivity is higher (i.e>95% 
inswab specimens or urine from males), which makes it appropriate for screening purposes 
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as it allows accurate diagnosis of symptomatic and asymptomatic infections.  The other 
advantages are that it does not require invasive specimens and the collected specimens do 
not need to be transported under as stringent conditions as for bacterial culture.  The 
disadvantages of NAAT is that it is more expensive, inhibition of the reaction may occur 
resulting in false negatives, the assay is complex and requires high technical skills and 
quality control, there is a lack of antibiotic resistance information and it can produce both 
false-negative and false-positive results (Meyer and Buder 2020; Verma and Sood 2016; 
Whiley et al. 2006). 
 
2.1.5 Treatment and Emerging Resistance 
Gonorrhoea can usually be treated with antimicrobials, however, this pathogen has been 
classified as a “superbug”, which has been able to develop high-level resistance to many of 
the available antimicrobials (including sulphonamides, penicillin, tetracyclines and 
ciprofloxacin) over the years (Costa-Lourenco et al. 2017).  This has limited the treatment 
options for this disease.  In 2016 the WHO guidelines recommended dual-therapy with 
ceftriaxone and azithromycin, which could possibly slow down the development of 
resistance to these drugs (Costa-Lourenco et al. 2017; WHO 2016).  Since there is no 
vaccine for gonorrhoea and the threat of developing high-level resistance to all 
antimicrobials is possible in the coming future, new treatment options need to be explored.  
Currently, efforts are being made to combine the available antimicrobials in novel ways, 
produce new antibiotics and discover alternative therapies to decelerate resistance 
development (Suay-Garcia and Perez-Gracia 2018). 
 
 
2.2 Human Immunodeficiency Virus 
 
2.2.1 Overview and Classification  
A new disease, Acquired Immunodeficiency Syndrome (AIDS), was first discovered in 
1981. However, the etiological agent of this disease, Human Immunodeficiency Virus 
(HIV) was only identified in 1983(Barre-Sinoussi et al. 1983; Sharp and Hahn 2011).  HIV 
is a retrovirus, which belongs to the family of Retroviridae and genus Lentivirus (Barre-
Sinoussi 1996; German Advisory Committee Blood 2016).  There are 2 types of HIV, viz. 
HIV-1 and HIV-2.  Globally, the most frequently occurring type is HIV-1.  HIV-2 is less 
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virulent than HIV-1 and is the most widespread HIV type found in West Africa, where it 
was first isolated in 1986 (Clavel et al. 1986; Santoro and Perno 2013).  HIV-1 includes 
four groups, viz. M (main), O (outlier), N (nonmajor and nonoutlier) and P.Group M has 
been further subdivided into nine subtypes or clades (viz. A, B, C, D, F, G, H, J and K) 
(Junqueira and Almeida 2016).  Group M also consists of  at least 58 circulating 
recombinant forms (Santoro and Perno 2013). 
 
2.2.2 Epidemiology 
HIV infection is a global health problem.  The UNAIDS global estimate for the number of 
people living with HIV in 2017 was 36.9 million (31.1 million–43.9 million), 
approximately 54% of which were in eastern and southern Africa.  Globally, there were 
approximately 1.8 million (1.4 million–2.4 million) new cases of HIV infection in 2017, 
with 45% of these cases in eastern and southern Africa.  In 2017, the estimated number of 
HIV infected individuals in the South African population was approximately 7.2 million 
(6.6 million – 7.2 million) and there were approximately 270 000 (240 000 – 300 000) new 
HIV infections (UNAIDS 2018).  In 2017, 27% of the South African HIV infected 
population aged 15 to 49 years were living in KwaZulu Natal (National Institiute of 
Communicable Diseases 2018). 
 
2.2.3 HIV Structure 
The spherical HIV virion (Figure 2.1) is enclosed by a host-derived lipid bilayer.  The lipid 
bilayer contains envelope protein complexes that are made up of a surface glycoprotein 
(gp120) and a transmembrane protein (gp41).  The matrix protein (p17) is attached to the 
inside of the membrane.  Within thevirion is the major capsid protein, p24, which encloses 
two single-stranded viral ribonucleic acid (RNA) copies as well as three enzymes,viz. 
protease, reverse transcriptase and integrase (Barre-Sinoussi 1996; Fanales-Belasio et al. 
2010). 
 
8 
 
 
 
Fig 2.1 Structure of the HIV.  Taken from Fanales-Belasio et al. (2010). 
 
 
2.2.4 HIV Life Cycle 
The replication cycle of HIV (Figure 2.2) commences with the attachment of the virus to 
the host cell surface.  Binding occurs when the HIV gp120 protein attaches to the CD4 
receptor on the host cell surface.  This causes gp120 to undergo a conformational change, 
exposing a domain that is able to bind to co-receptors (most commonly CCR5 and CXCR4) 
on the host cell.  This binding is followed by penetration of the host cell membrane by 
gp41, which thereafter undergoes a structural change allowing the HIV membrane to fuse 
with the host cell membrane, releasing the viral contents inside the host cell.  Within the 
cells, the viral reverse-transcriptase then reverse transcribes the viral RNA into double-
stranded deoxyribonucleic acid (dsDNA).  The dsDNA is thereafter transported to the 
nucleus, where the viral integrase incorporates it into the host cell DNA.  The host cell then 
produces viral messenger ribonucleic acid (mRNA) and this is transported into the 
cytoplasm.  In the cytoplasm, the viral mRNA is translated into viral proteins and also 
actsas viral genomic RNA that migrates towards the cell membrane, where assembly and 
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budding of the immature virion occurs.  The viral protease then cleaves the viral proteins, 
producing mature virions(Barre-Sinoussi 1996; Fanales-Belasio et al. 2010). 
 
 
Figure 2.2  HIV Life Cycle.  The HIV life cycle startswith the viral envelope fusing with 
the host cell membrane.  This enables the viral contents tobe released into the host 
cytoplasm, where the viral RNA is reverse-transcribed into dsDNA.  The viral dsDNA is 
then incorporated into the host cell DNA.  Following replication of the host cell, viral 
mRNA is produced and this is then translated into viral proteins.  The viral proteins and 
viral genomic RNA migrates towards the cell membrane, where budding of immature 
virions takes place.  Cleavage of the viral proteins within the virion by protease results in 
the formation of mature virions.  Taken from https://www.niaid.nih.gov/diseases-
conditions/hiv-replication-cycle (NIH). 
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2.2.5 Transmission and Clinical Manifestations 
HIV can be transmitted sexually, through parenteral exposure or through mother-to-child 
transmission (Berkley 1991; Patel et al. 2014).  Sexual transmission of HIV occurs during 
unprotected oral, vaginal or anal sex when mucus membranes are exposed to infected body 
fluids or when the virus enters the bloodstream.  Parenteral exposure of HIV includes 
exposure through needle-stick injuries, needle-sharing during intravenous drug use and 
receiving infected blood, blood products or organs.  The spread of HIV from a mother to a 
child can occur during pregnancy, during delivery or through breastfeeding (German 
Advisory Committee Blood 2016; Malani 2016; Patel et al. 2014).Following infection, the 
HIV clinical course follows three phases, viz. acute HIV infection, chronic HIV infection 
and AIDS (Figure 2.3) (An and Winkler 2010).  The acute phase of infection usually 
develops two to four weeks following exposure to the virus and the infected individual 
usually presents with flu-like symptoms including fever, rash, lymphadenopathy, 
pharyngitis and weight loss (Fanales-Belasio et al. 2010).  During the acute phase of 
infection, the viral load increases rapidly and the CD4+ lymphocyte count declines 
drastically since the virus attacks and replicates within these cells.  When an antiviral 
immune response is elicited, the viral load begins to decline.  At the same time, the CD4+ 
lymphocyte count begins to increase, however the count is lower than it was before the 
infection.  The high viral load present in the acute phase results in the newly infected 
individual being highly infectious.  The chronic phase of infection developsa few weeks 
following initial infection and it is associated with a decrease in the viral load.  The 
individual is asymptomatic in this phase of infection.  During the chronic phase, the CD4+ 
lymphocyte count gradually decreases until the count drops to < 200 cells/µL, which is the 
onset of the third phase of infection (AIDS).  The decrease in the immune cells increases 
the susceptibility to opportunistic pathogens.  The symptoms of AIDS include lymph node 
swelling, severe weight loss, fever, as well as respiratory and gastro-intestinal symptoms.  
The chances of developing cancers, including Kaposi’s sarcoma and lymphomas, are also 
increased in these individuals.  If left untreated, individuals with AIDS usually surviveabout 
three years (Bhatti et al. 2016; Fanales-Belasio et al. 2010). 
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Fig 2.3  HIV Clinical Course.  The illustration shows the 3 phases of HIV infection, viz. the 
acute phase (primary infection), the chronic phase (asymptomatic phase) and AIDS.  Taken 
from An and Winkler (2010). 
 
 
2.3 Endocervical Cells 
The female reproductive tract (FRT) is composed of the upper and lower FRT.  The lower FRT 
is composed of the vagina and ectocervixand both of these arecovered by non-polarised 
squamous epithelial cells. The upper FRT is composed of endocervix, uterus, salpinx and 
ovarium.  The lining of the endocervix and uterus is composed of a monolayer of polarised 
columnar epithelial cells (Wang et al. 2017).The epithelial cells  form the first line of defense 
against invading pathogens and guards against themby the production of mucus, secreting 
cationic antimicrobial peptides and by maintaining the integrity of the barrier through the 
formation of tight junctions (Stevens and Criss 2018).  The endocervix cells are held together 
by the epithelial junctional complexes, which prevent the paracellular movement of invading 
pathogens (Blaskewicz et al. 2011). However, the epithelial junction complex does not remain 
static and is able to assemble and disassemble to enable paracellular movement of solutes and 
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ions.  This paracellular permeability is regulated by extracellular and intracellular stimuli 
through signal transduction and reorganization of actin cytoskeleton (Rodgers and Fanning 
2011).  In a similar manner, pathogens have been shown to induce regulation of the apical 
junction, thereby altering the paracellular permeability (Nazli et al. 2010; Tapia et al. 2017). 
 
 
2.4 Tight Junctions 
Epithelial junctional complexes, which are responsible for attaching adjacent cells to each other, 
consists of the adherens junctions, tight junctions, gap junctions and desmosomes (Figure 2.4) 
(Bartle et al. 2018; Vedula et al. 2009).  The functions of the adherens junction are to initiate 
and stabilise adhesion between adjacent cells, regulate actin cytoskeleton and provide 
intracellular signaling.  The adherens junction is composed of the cadherins and catenins 
(Hartsock and Nelson 2008; Miyoshi and Takai 2008).  Cadherins (eg. E-cadherin) are the 
transmembrane proteins of the adherens junctions and the catenins (eg. β-catenin) are the 
cytoplasmic proteins that connect the cadherins to the actin cytoskeleton.   When the adherens 
junctions form, it causes the formation of the tight junctions.  However, maintenance of the 
tight junction organisation does not require E-cadherin (which is the core transmembrane 
protein of the adherens junction) (Hartsock and Nelson 2008).  The actin cytoskeleton of the 
cell is composed of the actin filaments, their accessory proteins and their regulatory proteins.  
The actin cytoskeleton is responsible for defining the shape of the cell, changing the shape of 
the cell during movement, regulation of intracellular motility and enabling cells to adhere to one 
another(Fletcher and Mullins 2010; Svitkina 2018).  Tight junctions are the areas between the 
plasma membranes of adjacent epithelial and endothelial cells, where the two cells join together 
to form a barrier.  The tight junctions have two functions.  The first function is to act as a 
selective barrier that controls paracellular movement (i.e the gate function) and the second 
function is to prevent apical or basolateral intramembrane lipid diffusion thereby physically 
separating the apical and basolateral sections of the plasma membrane(i.e the fence function) 
(Anderson and Van Itallie 2009; Balda and Matter 2009; Chiba et al. 2008; Miyoshi and Takai 
2008).  The tight junctions consist of the transmembrane proteins (which regulate the 
paracellular permeability) and the associated cytoplasmic proteins (which connect the 
transmembrane proteins to the actin cytoskeleton).  Transmembrane proteins include occludins, 
claudins, tricellulin and junctional adhesion molecules (JAMs), while the cytoplasmic proteins 
include zonula occludens-1 (ZO-1), ZO-2 andZO-3 (Balda and Matter 2008; Chiba et al. 2008).   
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Fig 2.4  Tight Junction.  This diagram shows the tight junction of epithelial cells, which is 
a component of the epithelial cell junctional complex.  The tight junction is made up of 
transmembrane proteins, which are linked to the cytoplasmic proteins (adaptors), which are 
attached to the cell actin filaments.  Taken from Vedula et al. (2009). 
 
 
2.4.1 Occludin 
Occludin was the first identified intramembrane protein (Chiba et al. 2008).  This protein is 
approximately 65kDa and is composed of four transmembrane domains, one intracellular 
loop,two extracellular loops and the N- and C-terminal cytoplasmic sections(Furuse 2010).  
The C-terminal domain is directly attached to ZO-1.  The two extracellular loops controls 
the accumulation of this protein at the junctions and it also regulates paracellular 
permeability, as occludin controls the diffusion of small hydrophilic molecules through the 
pararcellular route(Balda and Matter 2008; Furuse 2010). 
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2.4.2 Claudins 
Claudins are composed of 24 proteins, viz. claudins 1 – 24, which are 21 – 28kDa proteins.  
Claudins have four transmembrane domains, a short intracellular turn, two extracellular 
loops and the N- and C-terminal cytoplasmic sections. They are believed to be the backbone 
of the tight junction (Furuse 2010).  These proteins are capable of completely tightening the 
paracellular gap for solutes, as well as forming pores for selective ion paracellular 
permeability (Krause et al. 2008).  The claudin constitution within the tight junction 
regulates this ion selectivity through the paracellular route, since the changes in the 
expression of the claudin proteins are associated with changes to the ion selectivity (Balda 
and Matter 2008). 
 
2.4.3 ZO-1 
ZO-1 was the first tight junction protein that was identified (Stevenson et al. 1986).  ZO-1 
is an adaptor protein (Balda and Matter 2009).  The transmembrane proteins are associated 
with ZO-1, which is found in the intracellular part of the plasma membrane.  ZO-1 is 
associated with the actin filaments of the cytoskeleton, thereby enabling the tight junctions 
to connect the cytoskeletons of adjoining cells (Hartsock and Nelson 2008).  ZO-1 has been 
shown to perform a crucial part in coordination of epithelial actomysin and formation of the 
unified apical surface (Odenwald et al. 2018).  
 
 
2.5 STDs and HIV 
A strong association between HIV-1 and STDs became evident when an increased spread of 
HIV-1 infection in regions where STDs were endemic was observed (Cohen 1998).   Research 
has since suggested that a bidirectional relationship exists between HIV and “classic” STDs, 
including herpes, syphilis, gonorrhoea, trichomoniasis and chlamydia infection.A recent study 
showed that there was a high prevalence of asymptomatic STDs in a cohort of HIV-positive 
Zimbabwean women(Lowe et al. 2019).   STDs may increase the risk of HIV acquisition and 
transmission by causing breaks in the protective mucosal barrier, recruitment of susceptible 
immune cells to the point of infection or by increasing HIV-1 shedding in genital secretions 
(Chun et al. 2013; Cohen 1998; Kalichman et al. 2011; Piot and Laga 1989; Rottingen et al. 
2001).  Johnson and Lewis (2008) reported that genital tract infections resulted in an increase in 
the shedding of HIV, especially when the infection resulted in leukocyte recruitment in the 
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genital tract (Johnson and Lewis 2008).  Cohen et al. (1997) showed that urethritis in HIV-
positive men increases their infectiousness. They found that HIV-positive men with urethritis 
had an eight-fold higher concentration of HIV RNA in semen when compared to HIV-positive 
men without urethritis.  The highest concentration of HIV in semen was found in men infected 
with gonorrhoea.  The CD4 counts and the HIV RNA concentration in the blood of the two 
groups of men were similar.  The men with urethritis were given antibiotic therapy directed 
against STDs.  Two weeks following treatment, they found a significant decrease in the HIV 
RNA concentration in the semen of the treated men, with no significant change in the semen of 
the control group within that two-week period.  There was no change in the concentration of 
HIV RNA in the blood of the two groups of men(Cohen et al. 1997).Conversely, studies have 
shown that HIV may increase the risk of acquiring STDs, possibly resulting from disruption to 
the tight junctions of the protective epithelial barrier (Nazli et al. 2010; S. Tugizov 2016).  
Tugizov et al. (2013) demonstrated this by showing that exposure to HIV-1 resulted in 
disruption to the tight junctions of mucosal epithelia, which allowed paracellular migration of 
human papillomavirus.  HIV-1 has also been shown to disrupt the tight and adherens junctions 
in oral epithelial cells, which may facilitate the paracellular and cell-to-cell movement of HSV-
1 (Sufiawati and Tugizov 2014).    
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CHAPTER 3:  MATERIALS AND METHODS 
 
3.1 Materials and Ethics Approval 
The ME180 cervical cell line was used for the infection experiments.  This cell line is a human 
cervical cell line that was obtained from American Type Culture Collection (ATCC
®
 number 
HTB-33™).  Serum samples containing the HIV used in the infection experiments was obtained 
from the Africa Health Research Institute (AHRI).  The serum had been obtained from HIV 
subtype C infected, antiretroviral naïve patients participating in a research project of AHRI.  
Neisseria gonorrhoeae used was one of the clinical isolates from a former study carried out by 
Ramburan et al. (2019).  The isolate used was piliated and opa-positive from a male patient 
presenting with urethral discharge (Rambaran et al. 2019). 
Approval for the study was obtained from the University of KwaZulu-Natal Biomedical 
Research Ethics Committee (BE220/13). 
 
 
3.2 Tissue Culture 
ME180 cells were retrieved from frozen stock stored at -80°C.  To resuscitate the cells, a vial of 
frozen cells was thawed in a waterbath at 37°C and transferred to a 25 cm
2
 flask containing 10 
mL of warm McCoy’s 5Amedia (Gibco, Paisley, UK)  with 10% Foetal Bovine Serum (FBS) 
(BioWhittaker, Walkerville, USA).  The cells were incubated at 37°C in a humidified 
atmosphere with 5% CO2and viewed daily with an inverted microscope at 20x magnification to 
monitor morphological changes, cell density and to check for possible contamination.  The 
media was changed every two to three days until the cells reached approximately 90% 
confluency.  Media changes were performed by discarding the spent media, rinsing the cells 
with warm phosphate buffered saline (PBS) (Oxoid, Hampshire, England), pH 7.3,and finally 
by adding freshly prepared prewarmed McCoy’s 5A media (Gibco, Paisley, UK) containing 
10% FBS.  When 90% confluency was reached, the cells were passaged.  This procedure 
involved firstly discarding spent media, followed by washing the cells three times with warm 
PBS to remove unattached cells and FBS (which would inhibit the action of trypsin).  One 
milliliter of trypsin EDTA was then added to the flask and the flask was rotated to ensure 
proper coverage of trypsin over the cells.  This was followed by incubation at 37°C for 1 
minute.  The flask was then gently tapped until the cells detached.  One milliliter of FBS was 
added and the cells were either cryo-preserved, seeded into new flasks for propagation or 
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counted using a haemocytometer and thereafter seeded into the experimental wells.  To cryo-
preserve the cells, the trypsinised cells were transferred to a sterile tube.  An equal volume of 
ME180 freezing fluid was added drop by drop to the cells and gently swirled to mix.  The 
mixture was then transferred into cryovials and placed in the -80°C freezer in a closed 
polystyrene box to allow it to slowly reach -80°C.To seed the correct number of cells for the 
experiments, the cells were counted using a haemocytometer and the trypan blue exclusion 
assay.  A haemocytometer is a glass slide onto which a counting grid is etched using a laser 
(Figure 3.1).  A glass coverslip was placed over the counting grid of the haemocytometer.  
Twenty microlitres of cell suspension was added to a tube containing 20 µL of 0.4% trypan blue 
solution (1:2 dilution) and a drop of this mixture was transferred under the glass coverslip.  The 
cell suspension-trypan blue dye mixture moved under the coverslip due to capillary action.  The 
cells were then viewed under the inverted microscope at 10x magnification.  Viable cells are 
able to actively remove the trypan blue dye out of the cell and appear colourless, while the dead 
cells appear blue as they are not able to remove the dye from the cell.  The cells were counted in 
each of four corner squares on the haemocytometer (Figure 3.1).  For the cell count in each 
square, the cells within the square and on the top and left borders were included, while the cells 
on the bottom and right borders were excluded.  The following formula was used to calculate 
the number of cells in each millilitre of the cell suspension: 
 
   
Number of Cells/mL = 
number of cells 
x 10
4
x Dilution Factor 
4  
 
In this formula, the average number of cells in each of the four squares is first calculated by 
dividing the total number of cells in all four squares by four. Since the volume of each square is 
1 x 10
-4
 mL, the average number of cells in each square is then multiplied by 10
4 
to provide the 
number of cells per millilitre of cell suspension.  Finally, to correct for the dilution of the cells 
with trypan blue, the number of cells per millilitre is multiplied by the dilution factor (i.e two) 
to obtain the number of cells per millilitre in the original cell suspension. 
 
      The required number of cells was then seeded into the experimental wells. 
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Fig. 3.1 Haemocytometer.  The cell count is performed in the four corner squares of the 
counting grid.  In each square, the cells within the square and on the top and left borders are 
included, while the cells on the bottom and right borders are excluded from the count.  Taken 
from https://www.hemocytometer.org/hemocytometer-protocol/ 
 
 
3.3 Propagation and Storage of N. gonorrhoeae 
Neisseria gonorrhoeae was regrown from frozen stocks by culturing the organism onto GC agar 
plates enriched with yeast autolysate.  The plates were incubated for 24 hours at 37°C in an 
atmosphere with 5% CO2 and saturated water vapour.  With this culture a suspension was made 
in 10 mL Brain Heart Infusion (BHI) broth, with an optical density at 450 nm (OD450) of 1.  To 
allow settlement of clumps of bacteria, the tube containing the suspension was then placed 
upright for 1.5 hours at 37°C.  Following this, the upper 4 mL of the broth, containing the 
single-cell suspension, was carefully transferred to a sterile tube.  To confirm that a single-cell 
suspension was obtained, a Gram stain was performed.  To determine the number of organisms 
in this suspension, 10-foldserial dilutions of the suspension were prepared in BHI broth and 100 
L of each dilution was spread on GC agar plates enriched with yeast autolysate (90mm) using 
a L-shaped spreader (Whitehead Scientific, Cape Town, South Africa).  The plates were 
incubated at 37°C in a humidified atmosphere with 5% CO2 for 48 hours.  Following 
incubation, the plate with a number of colonies estimated to contain between 20 and 200 
colonies was chosen to determine the number of colony-forming units (CFU) of bacteria that 
were present in the basolateral media. The number of colonies was counted and the result 
multiplied by the dilution factor of the dilution used and multiplied by 10 to correct for the 
volume plated out. The test was done in triplicate.  The number of colonies was calculated as 
the average of the 3 readings. To store the N. gonorrhoeae from the GC agar plates, 1 mL of N. 
gonorrhoeae storage media was firstly added to a cryovial and a loopful of bacterial culture was 
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collected from the plate using a sterile loop and added to the storage media.  Sterile glass beads 
were then added to the cryovial, sealed and then vortexed to suspend the culture in the storage 
media.  The suspension was then stored in the -80°C freezer.  To prepare heat killed N. 
gonorrhoeae, N. gonorrhoeae suspended in the BHI broth was heated to 80°C for 30 minutes. 
 
 
3.4 Measuring the Concentration of  HIV 
To determine the number of viral particles per millilitre in the serum samples obtained from 
AHRI, RNA was isolated from the serum and the HIV Real-TM Quant kit (Sacace 
Biotechnologies, Como, Italy) was used to quantify the RNA.   
 
3.4.1 Viral RNA Extraction 
Viral RNA was extracted from 140 µL of the serum sample using the QiaAmp Viral RNA 
Mini kit (Qiagen, Hilden, Germany).  Negative and positive control samples supplied with 
the HIV Real-TM Quant kit (Sacace Biotechnologies, Como, Italy) were also prepared.  
The negative control sample contained 100 µL of the negative control reagent, while the 
positive control contained 90 µL of the negative control reagent and 10 µL of the positive 
control reagent.  Five microlitres of the internal control (IC) from the HIV Real-TM Quant 
kit (Sacace Biotechnologies, Como, Italy) was then added to all the samples and mixed 
thoroughly.  To each tube, 560 µL of Buffer AVL (containing carrier RNA) was added, 
mixed and then incubated at room temperature (which is between 22 - 23°C) for 10 minutes 
to enable lysis of the viral particles to occur.  The tubes were then centrifuged briefly and 
560 µL of absolute ethanol was added to each tube.  After mixing, the sample was then 
transferred to the QiaAmp Mini column and centrifuged at 6000 xg for 1 minute using a 
Heraeus Fresco 21 microcentrifuge (ThermoFisher Scientific, Germany).  Thereafter, 500 
µL Buffer AW1 was added to the QiaAmp Mini column and centrifuged at 6000x g for 1 
minute.  This was followed by adding 500 µl of Buffer AW2 to the QiaAmp Mini column 
and centrifuging at 20 000 x g for 3 minutes.  The QiaAmp Mini column was then 
transferred to a sterile microcentrifuge tube.  To elute the RNA, 40 µL of elution buffer was 
added to the column and the sample was incubated at room temperature for 1 minute.  The 
sample was then centrifuged at 6000x g for 1 minute and the eluted viral RNA was then 
stored at -80°C until required. 
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3.4.2 Quantification of Viral RNA 
Quantification of the extracted viral RNA was performed using the HIV Real-TM Quant kit 
(Sacace Biotechnologies, Como, Italy).  Firstly, 300 µL RT-PCR-mix-1 HIV and 200 µL 
RT-PCR-mix-2was added to the tube containing DTT.  For each PCR reaction, 12.5 µL of 
the mix prepared in the DTT vial was added to 0.5 µL of TaqF Polymerase and 0.25 µL of 
M-MLV to obtain a volume of 13.25 µL.  Twelve and a half microlitres of viral RNA was 
added to each PCR reaction in a 96 well PCR microtitre plate and mixed by gently pipetting 
up and down.  In each PCR run, 3 HIV quantitation standards (QS1 HIV, QS2 HIV and 
QS3 HIV), 3 IC quantitation standards (QS 1 IC, QS2 IC and QS3 IC) and 1 negative 
control (TE-Buffer) were included.  These were prepared by adding 12.5 µL of each of the 
reagents to separate wells containing 13.25 µL of the PCR reaction mix.  The PCR plate 
was sealed, centrifuged briefly and loaded onto the ABI 7500 Real Time PCR Instrument 
(Applied Biosystems) and the PCR was performed at the conditions shown in Table 3.1. 
 
 Table 3.1:  PCR Cycling Conditions for Quantification of Viral RNA 
 
 
The concentration of HIV in each of the control and experimental samples was calculated 
using the formula: 
 
Copies HIV/mL = 
HIV DNA copies per specimen 
x coefficient* 
IC DNA copies per specimen 
 
*The coefficient value is provided in the HIV Real-TM Quant Data Card provided with  
  the kit and it is specific for each lot number. 
Stage Temperature Time Number of cycles 
1 50°C 30 minutes 1 
2 95°C 15 minutes 1 
3 
95°C 20 seconds 
5 52°C 30 seconds 
72°C 30 seconds 
4 
95°C 20 seconds 
40 55°C 40 seconds 
72°C 30 seconds 
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3.5 Growing the Epithelial Cell Layer 
ME180 cells were prepared as described in section 3.2.  The cells were counted and 3.3 x 10
4
 
cells were seeded into the apical chamber of 6.5 mm Transwell
®
 inserts (Corning, Tewksbury, 
Massachusetts), which were collagen-coated polytetrafluoroethylene membrane tissue culture 
inserts with a pore size of 3 µm and a surface area of 0.33 cm
2
 (Figure 3.2) (D. Ye et al. 2015).  
The cells were allowed to proliferate until a fully confluent epithelial layer was obtained.  To 
confirm this, the transepithelial electrical resistance (TEER) of the layer was tested daily until a 
steady state of TEER was obtained.  To test the TEER, the Millicell® ERS-2 system (Millipore, 
Burlington, Massachusetts) was used.  The Millicell® ERS-2 system electrode was firstly 
decontaminated in 70% ethanol for 15 minutes, allowed to air-dry for 15 seconds and then 
placed in McCoy’s 5A media (Gibco, Paisley, United Kingdom).  The electrode was then ready 
to use.  To measure the electrical resistance across the Transwell® membrane, the shorter arm 
of the electrode was immersed in the apical chamber of the insert and the longer arm in the 
basolateral chamber of the well.  The resistance readings (in Ohms) were then recorded for the 
wells containing cells, as well as for blank wells (which contained no cells).  To calculate the 
resistance of the cell layers, the resistance reading of the blank was firstly subtracted from the 
resistance reading of the cells and this value was then multiplied by the area of the membrane 
(cm
2
).  When the readings reached a steady state of resistance, the epithelial layers were ready 
for infection.  To further confirm that a confluent epithelial layer was obtained, ZO-1 staining 
of the cells was carried out.  This procedure involved removing the media from the cells, 
followed by fixing the cells in 4% paraformaldehyde for 20 minutes at room temperature.  The 
cells were then rinsed three times with PBS (pH 7.3) and treated with 0.1% Triton X-100 for 7 
minutes at room temperature.  This was followed by rinsing the cells three times with PBS and 
blocking the cells in 3% bovine serum albumin (BSA) blocking solution for 30 minutes at room 
temperature.  A further three washes with PBS were done and the cells were then incubated for 
1 hour at room temperature in Rabbit anti-ZO-1 IgG antibody (1mg/ml) (Abcam, Cambridge, 
United Kingdom), which was diluted to 0.01 mg/ml 3% BSA.  After the incubation period, the 
cells were once again washed three times with PBS (pH 7.3) and incubated for 1 hour at room 
temperature in Alexa Fluor® 488 Goat Anti-Rabbit IgG H&L antibody (Abcam, Cambridge, 
United Kingdom) (2mg/ml), which was diluted 1 in 100 in 3% BSA.   Following this 
incubation, the cells were washed three times with PBS (pH 7.3) and the membrane was excised 
from the Transwell
®
 insert using a number 24 surgical blade (and transferred to a microscopy 
slide with the cells facing upwards.  A drop of Invitrogen Prolong Gold Antifade mountant with 
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DAPI (ThermoFisher Scientific, Waltham, Massachusetts) was added to the cells and this was 
then covered with a glass coverslip.  The cells were viewed under a fluorescent microscope 
(Leica DM3000, Wetzlar, Germany) at 100 x magnification.  Whether the confluent epithelial 
layer was intact was determined using the Blue Dextran Permeability Assay.  The epithelial cell 
layer was prepared as mentioned in section 3.2.  When a steady state of electrical resistance was 
obtained, the media was removed from the apical chamber of the Transwell
® 
insert and the 
insert was transferred to a well containing fresh media.  One hundred microlitres of blue dextran 
dye (Sigma, St Louis, USA) was added to the upper chamber of the Transwell
®
 insert.  Blue 
dextran dye was freshly prepared in McCoy’s 5A medium (Gibco, Paisley, United Kingdom) to 
obtain a final concentration of 2.3 mg/mL and the dye was filter sterilized using a 0.22 µm filter 
(Millipore, Burlington, Massachusetts).  Following an incubation of 1 hour, 100 µL of media 
from the basolateral chamber was removed and the optical density of the dye was measured at 
595 nm.  The optical density was expressed as a percentage of the dye added to the apical side. 
 
 
 
Fig 3.2  Transwell
®
 insert.This is a diagram of the Transwell insert.  The insert is placed into 
the well thereby creating an apical side and a basolateral side.  The cells are seeded into the 
apical side.  The cells attach to the filter membrane and form an epithelial layer.  Taken from 
Ye et al. (2015). 
 
 
3.6 Effect of Different N. gonorrhoeae MOIs on the Epithelial Layer 
To determine the effect that N.gonorrhoeae of different multiplicity of infections (MOIs) would 
have on the epithelial layer, a confluent epithelial layer was infected with different MOIs of N. 
gonorrhoeae.   
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3.6.1 Trans-epithelial Migration Assay with N. gonorrhoeae at Different MOIs 
The confluent epithelial layer was prepared on the Transwell inserts as described in section 
3.5.  The cells were then infected with N. gonorrhoeae at MOIs of 100,10, 1, 0.1 and 0.01.  
In addition, the cells were infected with heat killed N. gonorrhoeae at a MOI of 1.  At 30 
minutes and 24 hours post infection, the basolateral media was collected for colony forming 
unit (CFU) counts (as described in section 3.3).   
 
3.6.2 Tight Junction Gene Expression Assay for Different N.gonorrhoeae MOIs 
ME180 cells were prepared as described in section 3.2.  The cells were counted and 1 x 10
5
 
cells were seeded per well in collagen-coated 24 well plates.  The cells were monitored daily 
under an inverted microscope until a fully confluent epithelial layer was obtained.  When the 
cells were fully confluent, the epithelial layer was infected with N.gonorrhoeae only at a MOI 
of 100, 1, 0.1 and 0.01, as well as with heat killed N. gonorrhoeae at a MOI of 1, and incubated 
at 37°C in ahumidied atmosphere with 5% CO2.  At each time point 30 minutes and 24 hours 
post infection,  the cells were washed with PBS and 500 µL of Trisure reagent (Bioline, 
London, England) was added to each well and pipetted up and down a few times to lyse the 
cells.  The lysed samples were then collected into appropriately labeled microcentrifuge tubes 
and stored at -80°C for extraction of RNA. 
 
3.6.2.1 RNA Extraction 
Total RNA was extracted from the stored samples.  The RNA extraction was performed by 
firstly thawing the frozen samples and then adding 100 µL of chloroform to each of the 
samples.  The samples were incubated at room temperature for 5 minutes, shaken 
vigorously for 15 seconds and incubated at room temperature for 3 minutes.  Thereafter, the 
samples were centrifuged using a Heraeus Fresco 21 microcentrifuge (ThermoFisher 
Scientific, Germany) for 15 minutes at 12 000 x g.  The colorless upper aqueous phase, 
which contained the RNA, was carefully transferred to a sterile 15 mL tube.  An equal 
volume of cold 70% ethanol (prepared by adding 70 mL absolute ethanol to 30 mL Diethyl 
Pyrocarbonate (DEPC)-treated water) was added to the tube.  The RNA was then extracted 
from these samples using the RNeasy Mini Kit (Qiagen, Hilden, Germany) according to the 
manufacturer’s instructions.  Briefly, the sample was added to the RNeasy spin column and 
centrifuged at 8000 x g for 15 seconds.  The RNA, which was bound to the spin column 
membrane, was then washed once with Buffer RW1 and thereafter washed twice with 
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Buffer RPE.  The RNA was then eluted in 40 µL of ribonuclease (RNase)-free water.  The 
quantity and purity of the RNA was determined using a Nanodrop spectrophotometer.  This 
was followed by deoxyribonuclease (DNase) treatment of the RNA.   
 
3.6.2.2 DNase Treatment of RNA 
One microgram of the extracted RNA was DNase treated using DNase I (ThermoFisher 
Scientific, Waltham, Massachusetts) according to the manufacturer’s instructions.  In a 0.2 
mL PCR tube, 1 µg of RNA was added to 1 µL of 10 X reaction buffer, 1 µL DNase I and 
DEPC-treated water to obtain a final volume of 10 µL.  The sample was then incubated for 
30 minutes at 37°C.  One microlitre of 50 mM ethylenediaminetetraacetic acid (EDTA) was 
added to each tube and further incubated for 10 minutes at 65°C.  The RNA was then used 
to prepare complementary deoxyribonucleic acid (cDNA) and the remaining RNA was 
stored at -80°C. 
 
3.6.2.3 cDNA Synthesis 
The DNase-treated RNA samples were reverse transcribed into cDNA using the High-
Capacity cDNA Reverse Transcription kit (ThermoFisher Scientific, Waltham, 
Massachusetts) according to the manufacturer’s instructions.  The cDNA master mix was 
prepared by adding 2.0 µL 10X RT Buffer, 0.8 µL 25X dNTP Mix (100mM), 2 µL10X RT 
Random Primers, 1 µL MultiScribe™ Reverse Transcriptase and 1.0 µL RNase Inhibitor 
per reaction. One microgram of RNA was used in each reaction and the volume of the water 
was adjusted to obtain a final volume of 20 µL.  Each reaction was prepared in PCR tubes 
and loaded onto a thermal cycler.  The PCR was performed at the cycling conditions shown 
in Table 3.2. 
 
Table 3.2.  PCR Cycling Conditions for cDNA Synthesis from Epithelial Cell RNA 
 
Temperature Time Number of cycles 
25°C 10 minutes 1 
37°C 120 minutes 1 
85°C 5 minutes 1 
4°C Hold  
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The cDNA was then stored at -20°C until required. 
 
3.6.2.4 Real Time PCR 
The FastStart Essential DNA Green Master kit was used according to the manufacturer’s 
instructions.  This kit uses SYBR Green technology.  Each 20 µL reaction contained 10 µL 
Master Mix, 1µL forward primer (0.25 µM final), 1 µL reverse primer (0.25 µM final), 3 
µL PCR grade water and 5 µL cDNA.  The tight junction gene primers, as well as GAPDH, 
can be seen in Table 3.3.  Amplification was performed in the ABI 7500 Real Time PCR 
Instrument (Applied Biosystems, Life Technologies) using a 96-well microtitre reaction 
plate.  The cycling conditions used can be seen in Table 3.4. 
 
Table 3.3.   PCR Primer Sequences for Tight Junction Protein Coding Genes 
 
Gene Primer Sequence References 
Occludin 
Forward Primer:  CATTGCCATCTTTGCCTGTG 
Reverse Primer:  AGCCATAACCATAGCCATAGC 
(Nazli et al. 2010) 
Claudin 4 
Forward Primer:   TCATCGGCAGCAACATTGTC 
Reverse Primer:  GCAGTGCCAGCAGCGAGT 
(P. Ye 2012) 
Claudin 5 
Forward Primer:   TCATCGGCAGCAACATTGTC 
Reverse Primer:  GCAGTGCCAGCAGCGAGT 
(P. Ye 2012) 
GAPDH 
Forward Primer:   TCTCTGCTCCTCCTGTTC 
Reverse Primer:  CTCCGACCTTCACCTTCC 
(Nazli et al. 2010) 
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Table 3.4.  Real Time PCR Cycling Conditions for Gene Expression Assay 
 
 
 
 
 
 
 
 
 
 
 
 
A melt curve was performed to confirm the specificity of the amplification.  Analysis of the PCR 
data was carried out using the comparative CT method.  Briefly, the comparative CT method 
calculates the fold change (2
-ΔΔCT
) of the tight junction gene in the infected sample compared to the 
uninfected (control) sample using the following equations: 
 
ΔΔCT = [(CT target – CT reference) sample – (CT target – CT reference) calibrator)] 
 
Expression Fold Change = 2
-ΔΔCT
 
 
where: 2
-ΔΔCT
 refers to the fold change, CT refers to the threshold cycle, target refers to the tight junction 
gene, reference refers to the housekeeping gene and calibrator refers to the control or uninfected samples 
 
 
The methodology from section 3.6.2 was adapted for the gene expression assay. The cells were 
seeded onto collagen-coated 24 well plates and when the cells were fully confluent, the epithelial 
layer was infected with N. gonorrhoeae only, HIV only or a combination of N. gonorrhoeae and 
HIV at a MOI of 1 and incubated at 37°C in a humidified atmosphere with 5% CO2.  At each time 
point (i.e 30 minutes, 6 hours and 24 hours) post infection, the cells were washed with PBS and 500 
µL of Trisure reagent (Bioline, London, England) was added to each well and pipetted up and down 
a few times to lyse the cells.  The lysed samples were then collected into appropriately labeled 
Stage Temperature Time Number of cycles 
 50°C 2 minutes 1 
Pre-incubation 94°C 10 minutes 1 
Amplification 
94°C 15 seconds 
40 
62°C 1 minute 
Melting Curve 
95°C 15 seconds 
1 
60°C 1 minute 
95°C 30 seconds 
60°C 15 seconds 
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microcentrifuge tubes and stored at -80°C for extraction of RNA. The RNA extraction, DNAse 
treatment, cDNA synthesis and Real Time PCR was performed as described in sections 3.6.2.1, 
3.6.2.2, 3.6.2.3 and 3.6.2.4 respectively.  The primer sequences for the tight junction genes, as well 
as GAPDH can be seen in Table 3.5. 
 
Table 3.5.   PCR Primer Sequences for the Tight Junction Protein Coding Genes 
Gene Primer Sequence References 
ZO-1 
Forward Primer:  AGAAGGATGTTTATCGTCGCATT 
Reverse Primer:  CCAAGAGCCCAGTTTTCCAT 
(P. Ye 2012) 
Occludin 
Forward Primer:  CATTGCCATCTTTGCCTGTG 
Reverse Primer:  AGCCATAACCATAGCCATAGC 
(Nazli et al. 2010) 
Claudin 1 
Forward Primer:  CAATGCCAGGTACGAATTTGG 
Reverse Primer:  TGGATAGGGCCTTGGTGTTG 
(P. Ye 2012) 
Claudin 4 
Forward Primer:   TCATCGGCAGCAACATTGTC 
Reverse Primer:  GCAGTGCCAGCAGCGAGT 
(P. Ye 2012) 
Claudin 5 
Forward Primer:   TCATCGGCAGCAACATTGTC 
Reverse Primer:  GCAGTGCCAGCAGCGAGT 
(P. Ye 2012) 
GAPDH 
Forward Primer:   TCTCTGCTCCTCCTGTTC 
Reverse Primer:  CTCCGACCTTCACCTTCC 
(Nazli et al. 2010) 
 
 
3.7 Migration of Heat Killed N. gonorrhoeae 
The heat killed N. gonorrhoeae was prepared as described in section 3.3.  The confluent 
epithelial layer was prepared on the Transwell inserts as described in section 3.5 and infected 
with the heat killed N. gonorrhoeae.  At 24 hours post infection, the basolateral media was 
collected, genomic DNA was extracted and conventional pili protein gene PCR was performed. 
 
 
3.7.1 DNA Extraction of N. gonorrhoeae 
DNA was extracted from the basolateral media using the Wizard Genomic DNA 
Purification Kit (Promega, USA).  The basolateral media was centrifuged for 2 minutes at 
14 000 x g.  The supernatant was then discarded and 600 µL of nuclei lysis solution was 
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added, mixed gently and incubated for 5 minutes at 80°C.  The suspension was then 
allowed to cool to room temperature and thereafter 3µL of RNase solution was added, 
mixed and incubated at 37°C for 30 minutes.  The suspension was then allowed to cool to 
room temperature and 200 µL of protein precipitation solution was added, vortexed and 
incubated on ice for 5 minutes.  The suspension was then centrifuged for 3 minutes at 14 
000 x g.  The supernatant was then transferred to a sterile microcentrifuge tube and 600 µL 
of isopropanol was added and inverted to mix until thread-like strands of DNA were visible.  
The tube was then centrifuged for 2 minutes at 14 000 x g.  The supernatant was discarded 
and 600µL of 70 % ethanol was added, inverted to mix and centrifuged for 2 minutes at 14 
000 xg.  The ethanol was discarded allowed to air dry for 10 to 15 minutes.  The DNA 
pellet was rehydrated in 100 µL of nuclease free water overnight at 4°C.  The DNA was 
then used immediately or stored at -20°C. 
 
3.7.2 Conventional Pili Protein Gene PCR 
The DreamTaq PCR Master Mix (2X) kit (ThermoFisher Scientific, Waltham, 
Massachusetts) was used according to the manufacturer’s instructions.  Each 50 µL reaction 
contained 25 µL DreamTaqPCRMaster Mix (2X), 1µL forward primer (0.25 µM final), 1 
µL reverse primer (0.25 µM final), 21 µL PCR grade water and 2 µL DNA.  The Pili 
protein  gene forward primersequence was 5’ GGCTTTCCCCTTTCAATTAGGAG 3’ and 
the reverse primer sequence was 5’ GCAGGTGACGGCAGGTGC 3’.  Amplification was 
performed in the ABI 7500 Real Time PCR Instrument (Applied Biosystems, Life 
Technologies).  The cycling conditions used can be seen in Table 3.6. 
 
                  Table 3.6.  PCR Cycling Conditions for Pili Protein Gene PCR 
 
 
 
 
 
 
 
 
 
Stage Temperature Time Number of cycles 
Initial Denaturation 95°C 4 minutes 1 
Amplification 
95°C 30 seconds 
30 55°C 30 seconds 
72°C 1 minute 
Final Extension 72°C 5 minutes 1 
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3.8 N. gonorrhoeae and HIV Migration Assays 
To determine the effect that N. gonorrhoeae or HIV would have on an intact cervical epithelial 
layer, a confluent epithelial layer was infected with N. gonorrhoeae only, HIV only or a 
combination of N. gonorrhoeae and HIV.  At each time point the basolateral media was 
collected.  The N. gonorrhoeae count was performed immediately after collection, while the 
basolateral media collected for the HIV migration assay was stored at -80°C until required. 
 
3.8.1 Transmigration of N. gonorrhoeae 
The N. gonorrhoeae migration assay was performed on the basolateral media collected at 
time points 30 minutes, 6 hours, 16 hours and 24 hours from the wells infected with either 
N. gonorrhoeae only or with N. gonorrhoeae and HIV simultaneously.  To determine the 
number of colonies in the basolateral media, CFU counts were performed as described in 
section 3.3.  The percentage of N. gonorrhoeae that had migrated to the basolateral media 
was determined by dividing the number of N. gonorrhoeae calculated from the CFU count 
by the initial inoculums added to the apical chamber.  To determine why there was a high 
percentage of N. gonorrhoeae in the basolateral media at 24 hours post infection, the 
number of N. gonorrhoeae that had migrated to the basolateral media at 30 minutes was 
calculated and that number of N. gonorrhoeae was then suspended in 1mL of McCoy’s 5A 
media in a well of a 24 well tissue culture plate and incubated at 37°C in a humidified 
atmosphere with 5% CO2 for 24 hours. Following incubation, CFU counts were performed 
as described in section 3.3. 
 
 
3.8.2 HIV Count Post Migration 
The HIV migration assay was carried out on the stored basolateral media collected at time 
points 30 minutes, 6 hours and 24 hours from the wells infected with either HIV only or 
with N. gonorrhoeae and HIV simultaneously.  Viral RNA was first isolated from the 
sample and the RNA was then quantified using the HIV Real-TM Quant kit (Sacace 
Biotechnologies, Como, Italy).The viral RNA was extracted from the stored basolateral 
media using the QiaAmp Viral RNA Mini kit (Qiagen, Hilden, Germany).  The samples 
were first allowed to thaw and then 500 µL of sample was transferred to a sterile 
microcentrifuge tube and centrifuged at 4°C at 21 000 x g for 1 hour. The supernatant was 
removed from the tube, leaving behind 140 µL of supernatant above the pellet.  This step 
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was done carefully to ensure that the pellet was not disturbed.  The pellet was then 
resuspended in the remaining supernatant.  Negative and positive control samples supplied 
with the HIV Real-TM Quant kit (Sacace Biotechnologies, Como, Italy) were also prepared 
and the RNA extraction was performed as described in section 3.4.1.  Quantification of the 
viral RNA was carried out as described in section 3.4.2.  To determine the percentage of 
HIV that transmigrated across the epithelial layer to the basolateral side, the number of 
copies HIV per millitre was divided by the initial number of HIV that was added to the 
apical chamber of the Transwell insert multiplied by 100. 
 
 
3.8.3 Blue Dextran Permeability Assay 
To determine whether infection with the organisms resulted in damage to the epithelial 
layer, the Blue Dextran permeability assay was performed.  The confluent epithelial layer 
was prepared as described in section 3.5.  The cells were then infected with N. gonorrhoeae 
only, HIV only or a combination of N. gonorrhoeae and HIV at a MOI of 1.  At the 
appropriate time points (i.e 30 minutes, 6 hours and 24 hours), the apical media of the 
Transwell® inserts was removed and the insert was transferred into a well containing fresh 
media.  One hundred microlitres (100 µL) of the blue dextran dye was then added to the 
upper chamber of the insert and incubated for 1 hour.  Following the incubation, 100µL of 
media from the basolateral chamber was removed and the optical density of the dye was 
measured at 595nm.  The optical density was expressed as a percentage of the dye added to 
the apical side. 
 
 
 
3.9 Tight Junction Protein Staining 
ME180 cells were prepared (as described in section 3.2) and seeded onto collagen coated acid-
washed glass coverslips placed in 24 well tissue culture plates.  The cells were monitored daily 
until a confluent monolayer was obtained.  At this point, the cells were infected with 
N.gonorrhoeae only, HIV only or a combination of N. gonorrhoeae and HIV at a MOI of 1 and 
incubated at 37°C with 5% CO2.  At each time point (i.e 30 minutes, 6 hours and 24 hours) post 
infection, the cells were washed with PBS (pH 7.3) and fixed in 4% paraformaldehyde for 20 
minutes at room temperature.  The cells were then rinsed three times with PBS and treated with 
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0.1% Triton X-100 for 7 minutes at room temperature.  This was followed by rinsing the cells 
three times with PBS and suspending the cells in 3% bovine serum albumin (BSA) in PBS 
blocking solution for 30 minutes at room temperature.  A further three washes were done with 
PBS (pH 7.3) and the cells were then incubated for 1 hour at room temperature in primary 
antibody (1mg/mL). The primary antibody was anti-occludin rabbit IgG antibody (Abcam, 
Cambridge, UK).  After the incubation, the cells were once again washed three times with PBS 
and incubated for 1 hour at room temperature in Alexa Fluor
®
 488 Goat Anti-Rabbit IgG H&L 
antibody (2mg/mL) (Abcam, Cambridge, UK).   Following this incubation period, the cells 
were washed three times with PBS.  A drop of Invitrogen Prolong Gold Antifade mountant with 
DAPI (ThermoFisher Scientific) was placed on a microscope slide and the coverslip was 
carefully placed on the drop of mountant, with the cells facing the slide.  The cells were viewed 
under a fluorescent microscope (Leica DM3000, Wetzlar, Germany) at 100x magnification. 
 
 
3.10 Statistical Analysis 
Statistical analysis was performed by a statistician using Stata statistical software.  N. 
gonorrhoeae migration was summarized as the mean and standard deviation of the percentage 
of N. gonorrhoeae that migrated to the basolateral media.  At each time point, the migration of 
N. gonorrhoeae for the N. gonorrhoeae only and the N. gonorrhoeae and HIV infections were 
compared using Wilcoxon rank sum test.  For HIV migration, comparisons between N. 
gonorrhoeae and N. gonorrhoeae and HIV infections were made using the Wilcoxon rank sum 
tests.  The fold change in gene expression to the control was calculated for each organism at 
each time point.  The data was summarized as the mean and standard error of the fold change of 
the fold change and the Wilcoxon sign rank test was used to compare the mean fold change to 
one (indicating no difference).  The Wilcoxon rank sum test was then used to compare the N. 
gonorrhoeae only to the N. gonorrhoeae and HIV fold change at 24 hours. 
 
The formula and preparation method of all media and reagents used in section 3 is described in the 
Appendix. 
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CHAPTER 4: RESULTS 
 
4.1 Concentration of Microbes  
The number of N. gonorrhoeae in the single-cell suspension prepared as described in section 
3.3 was 4.7 x 10
8
cfu/mL.  The viral load in the HIV serum determined as described in section 
3.4 was 9.4 x 10
12
 copies/mL. 
 
4.2 Epithelial Layer for Transmigration Assay 
The ME180 cells were seeded onto Transwell
®
 inserts as mentioned in section 3.5.  To 
determine when the cells had formed a confluent epithelial layer with intact tight junctions, the 
TEER was monitored daily until a steady state was reached.  Although a confluent epithelial 
layer was visible under the microscope approximately 3 days post seeding, the resistance 
readings only reached a steady state at 6 days post seeding.  Table 4.1 shows the TEER of 2 
experiments.  To further confirm that the tight junctions were intact, ZO-1 immunofluorescence 
staining of the epithelial layer at 6 days post seeding was performed, as described in section 3.5.  
The results showed that the ZO-1 tight junction proteins were intact in the epithelial layer 
(Figure 4.1).  In addition, the blue dextran permeability assay was performed to test the 
permeability of the epithelial layer when the steady state of electrical resistance was reached.  
There was no leakage of the dye to the basolateral media, thus confirming that the tight 
junctions of the epithelial layer were intact. 
 
Table 4.1 Trans-epithelial Resistance Readings of Confluent Epithelial Layer 
 
 
 
 
 
 
 
 
 
 
 
Days  
(Post Seeding) 
Time  
(hours) 
TEER 
(Ω.cm2) 
TEER Range 
(Ω.cm2) 
1 24 3.6 (3.3 – 4) 
2 48 4.3 (4 – 4.62) 
3 72 7.3 (7.3 – 7.3) 
4 96 10.2 (9.9 – 10.6) 
5 120 11.9 (11.9 – 11.9) 
6 144 12.5 (12.2 – 12.9) 
7 168 12.5 (12.5 – 12.5) 
8 192 12.5 
(12.5 – 12.5) 
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Figure 4.1.  ZO-1 staining of the epithelial layer.  ZO1 staining of the epithelial layer 
showed that a confluent epithelial layer formed with intact tight junctions, which are indicated 
by the arrows. 
 
 
4.3 Effect of Different N. gonorrhoeae MOIs on the Epithelial Layer 
 
4.3.1 Trans-epithelial Migration Assay with N.gonorrhoeae at Different MOIs 
The confluent epithelial layer was infected with N.gonorrhoeae at different MOIs (viz. 
MOI of 100, MOI of 10, MOI of 1, MOI of 0.1 and MOI of 0.01), as well as with heat 
killed N.gonorrhoeae to determine the effect of the concentration of bacteria on trans-
epithelial migration (section 3.6.1).  At 30 minutes, the highest migration was observed at a 
MOI of 1 (Figure 4.2A).  At MOIs of 100 and 10, N.gonorrhoeae was able to migrate 
across the epithelial layer, but in number of colonies too low to count reliably (explained in 
section 3.3).  At this time point there was no migration of N.gonorrhoeae at a MOI of 0.1, 
0.01 nor with the heat killed bacteria. At 24 hours post infection, the number of 
N.gonorrhoeae that was present in the basolateral media was similar at MOI of 100, 10, 1 
and 0.1 (Figure 4.2B).  The number of migrating organisms was lowest at the MOI of 0.01.  
There was no heat killed N.gonorrhoeae detected in the basolateral media.   
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A                                                                                             
 
       B 
 
Figure 4.2.  N. gonorrhoeae Migration for Different MOIs.  The graphs show the results 
of the N. gonorrhoeae migration assay using different MOIs of N. gonorrhoeae (i.e MOI of 
100, MOI of 10, MOI of 1, MOI of 0.1 and MOI of 0.01), as well as heat killed N. 
gonorrhoeae, at 30 minutes (A) and 24 hours (B).  The results show that at 30 minutes, N. 
gonorrhoeae was able to migrate across the epithelial layer at a MOI of 1.  At 24 hours, the 
number of N. gonorrhoeae that was able to migrate across the epithelial layer was similar 
for the MOI of 100, 10, 1 and 0.1, however the migration was lower at MOI of 0.01.  The 
heat killed N. gonorrhoeae did not move across the epithelial layer.  Measurements are the 
mean values of 9 and the error bars indicate the SEM. 
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4.3.2 Tight Junction Gene Expression Assay for Different N. gonorrhoeae MOIs 
In an attempt to determine how N. gonorrhoeae at different MOIs would affect the 
expression of tight junction protein coding genes, confluent epithelial cell layers were 
infected with N. gonorrhoeae at a MOI of 100, 1, 0.1and 0.01, as well as with heat killed N. 
gonorrhoeae (section 3.6.2).  The tight junction protein gene expression at 30 minutes post 
infection and 24 hours post infection can be seen in Figure 4.3 (A) and Figure 4.3 (B), 
respectively.   
A 
B  
 
Figure 4.3.  Tight Junction Protein Gene Expression Assay for Different N. gonorrhoeae 
MOIs.  The graphs show the fold change of the expression of the tight junction genes in the cells 
infected with N.gonorrhoeaeat different MOIs (i.e MOI of 100, MOI of 10, MOI of 1, MOI of 0.1 
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and MOI of 0.01), as well as heat killed N.gonorrhoeae, at 30minutes post infection (A) and 24 
hours post infection (B).  A fold change of one implies that the expression of the target gene in the 
infected cells is the same as in the uninfected cells.  Measurements are the mean values of 9 
experiments and the error bars indicate the standard error of the mean (SEM). 
 
 
4.4  Migration of Heat Killed N. gonorrhoeae 
The heat killed N. gonorrhoeae was not detected in the basolateral media in the trans-epithelial 
migration assay (as shown in section 4.3.1).  Since heat killed N. gonorrhoeae would not be 
viable and would therefore not produce colonies in the colony-count assay, conventional pili 
protein gene PCR was performed on DNA extracted from the basolateral media to determine if 
the heat killed N. gonorrhoeae was able to migrate across the epithelial layer.  The results can 
be seen in Figure 4.4.  This shows that the N. gonorrhoeae strain used does express the pili 
protein gene and it also shows that killed N. gonorrhoeae was not able to migrate across the 
epithelial layer which shows that the migration of N. gonorrhoeae is a process that involves live 
bacterial cells. 
 
 
 
Figure 4.4 PCR Products of the N. gonorrhoeae pilin gene.  The results of amplification of 
pilin gene in DNA extracted from N. gonorrhoeae (lane 2), heat killed N. gonorrhoeae (L5) and 
heat killed N.gonorrhoeae from the basolateral media 24 hours post infection (L6).  Lane 1 (L1) 
contains the 50 bp DNA ladder, lane 4 (L4) contains the negative control and lane 3 (L3) is 
empty.  The PCR product is 516bp. 
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4.5 N. gonorrhoeae and HIV Migration Assays 
The confluent epithelial layer was exposed to N. gonorrhoeae only, HIV only or a combination 
of N. gonorrhoeae and HIV.  At each time point (i.e 30 minutes, 6 hours and 24 hours) post 
infection, the blue dextran permeability assay was carried out as described in section 3.8.3to 
determine if exposure to the microorganisms affected the tight junctions.  The results showed 
that at each time point there was no leakage of the blue dextran from the apical to the 
basolateral compartment, which shows that the tight junctions remained intact when exposed to 
both microbes individually and together.   
 
The results of the N. gonorrhoeae migration assay showed that even though the tight junctions 
were intact, the organism had started to move across the epithelial layer as early as 30minutes 
post infection (Table 4.2).  There was minimal movement of the microorganism across the 
epithelial layer until 16 hours post infection. At 16 hours post infection the number of colony 
forming units in the basolateral media was for N. gonorrhoeae only 92 % of the inoculum. At 
24 hours post infection for N. gonorrhoeae only and from 16 hours post infection for the 
combination with HIV, the percentage of N. gonorrhoeae that was present in the basolateral 
media had increased above 100% of the inoculum added to the apical compartment.  To confirm 
that the high percentage of N. gonorrhoeae that was present in the basolateral media was due to 
multiplication of the microorganisms that had migrated across the epithelial layer, the same 
number of N. gonorrhoeae that migrated through to the basolateral media at 30 minutes was 
suspended in media and incubated for 24 hours as described in section 3.8.1.  The result 
obtained confirmed that the high percentage of N. gonorrhoeae shown at 24 hours was indeed 
due to growth of the bacteria in the media.  Further migration beyond 6 hours is likely to have 
taken place in addition to multiplication. How much of the 92 % at 16 hours for N. gonorrhoeae 
only is the result of migration could not be established. 
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                             Table 4.2  Results of N. gonorrhoeae Migration Assay 
 
N.gonorrhoeaeOnly N.gonorrhoeaeand HIV  
 
Mean Migration SD Mean Migration SD 
30 minutes 0.61 % 0.25 0.63 % 0.09 
6 hours 1.02 % 0.14 2.44 % 0.17 
16 hours 92 % 7.48 225.67 % 8.98 
24 hours 600 % 126.75 3260 % 395.1 
 
At each time point, more colony forming units of N. gonorrhoeaewere found in the basolateral 
medium with HIV present as compared to N. gonorrhoeae alone. This difference was 
statistically significant at time points, 6 hours (p = 0.0039), 16 hours (p = 0.0039) and 24 hours 
(p = 0.0039). 
 
The percentage of HIV that transmigrated across the confluent epithelial layer was determined 
as described in section 3.8.2.  The results obtained for the infection with HIV and N. 
gonorrhoeae simultaneously and HIV only can be seen in Figure 4.5.  
 
 
 
 
Fig 4.5  Results of HIV Migration Assay.  The results of the HIV migration assay showed 
that there was less than 4% migration of HIV across the epithelial layer.Measurements are the 
mean values of 3 experiments and the error bars indicate the SEM.  The difference between N. 
gonorrhoeae and HIV was not significantly different at 30 minutes (p = 0.12), 6 hours (p = 
0.12) and 24 hours (p = 0.12).  The statistical method used was the Wilcoxon rank sum test. 
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The percentage of HIV that was able to migrate across the epithelial layer in each of the 
experiments was less than 4%. The highest amount of HIV in the basolateral fluid was seen at 
6 hours post inoculation in the absence of N. gonorrhoeae.  No migration of HIV was observed 
with N. gonorrhoeae present.  
 
 
4.6 Gene Expression Assay 
To determine if exposure to HIV only, N. gonorrhoeae only or a combination of N. 
gonorrhoeae and HIV altered the expression levels of the tight junction genes, the gene 
expression assay was performed as described at the end of section 3.6.2.  The RNA extracted 
from the epithelial cells had concentrations that ranged from 95 – 145 ng/µL and the purity 
ranged from 1.8 to 2.0.The results of the tight junction gene expression assay show the fold 
change in ZO-1 (Figure 4.6), occludin (Figure 4.7), claudin-1(Figure 4.8), claudin-4 (Figure 
4.9) and (Figure 4.10) for N. gonorrhoeae only, N. gonorrhoeae and HIV simultaneously and 
HIV only.  The results for exposure with HIV only showed that the virus did not seem to alter 
the expression of the tight junction genes, as compared to the uninfected control cells (Figure 
4.11 C).  Exposure to N. gonorrhoeae only or a combination of N. gonorrhoeae and HIV 
(Figure 4.11 A and 4.11 B, respectively) did not appear to alter the tight junction gene 
expression at time points 30 minutes and 6 hours.  However, 24 hours post exposure there was a 
downregulation of the claudin 5 gene expression, as well as an upregulation in the claudin 4 and 
occludin gene expression.  This difference was statistically significant for claudin 5 with a p 
value of 0.00. 
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Fig 4.6  Graph showing fold change of ZO-1 gene expression following exposure to N. 
gonorrhoeae, N. gonorrhoeae and HIV simultaneously and HIV only.  This graph shows the fold 
change of the expression of the ZO-1 tight junction gene in the ME180 cells infected with N. 
gonorrhoeae, N. gonorrhoeae and HIV simultaneously and HIV only, as compared to the 
uninfected cells, at time points 30 minutes, 6 hours and 24 hours.  A fold change of one implies that 
the expression of the target gene in the infected cells is the same as in the uninfected cells. 
Measurements are the mean values of six to nine experiments and the error bars indicate the 
standard error of the mean (SEM).  The fold change between N. gonorrhoeae only and the 
uninfected cells was not significantly different at 30 minutes (p = 0.4), but was significantly 
different at 6 hours (p = 0.02) and 24 hours (p = 0.02).  The fold change between N. gonorrhoeae 
and HIV simultaneously and the uninfected cells was not significantly different at 30 minutes (p = 
0.3), but was significantly different at 6 hours (p = 0.02) and 24 hours (p = 0.02).  The fold change 
between HIV only and the uninfected cells was not significantly different at 30 minutes (p = 0.6) 
and 6 hours (p = 0.5), but was significantly different at 24 hours (p = 0.04).  The statistical analysis 
was done using a Wilcoxon sign rank test. 
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Fig 4.7  Graph showing fold change of occludin gene expression following exposure to N. 
gonorrhoeae, N. gonorrhoeae and HIV simultaneously and HIV only.  This graph shows the fold 
change of the expression of the occludin tight junction gene in the ME180 cells infected with N. 
gonorrhoeae, N. gonorrhoeae and HIV simultaneously and HIV only, as compared to the 
uninfected cells, at time points 30 minutes, 6 hours and 24 hours.  A fold change of one implies that 
the expression of the target gene in the infected cells is the same as in the uninfected cells. 
Measurements are the mean values of six to nine experiments and the error bars indicate the SEM.  
The fold change between N. gonorrhoeae only and the uninfected cells was significantly different at 
30 minutes (p = 0.009), 6 hours (p = 0.04) and 24 hours (p = 0.03).  The fold change between N. 
gonorrhoeae and HIV simultaneously and the uninfected cells was significantly different at 30 
minutes (p = 0.01), 6 hours (p = 0.009) and 24 hours (p = 0.008).  The fold change between 
HIVonly  and the uninfected cells was not significantly different at 30 minutes (p = 0.1) and 6 hours 
(p = 0.09), but was significantly different at 24 hours (p = 0.01).  The statistical analysis was done 
using a Wilcoxon sign rank test. 
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Fig 4.8  Graph showing fold change of Claudin1 gene expression following exposure to N. 
gonorrhoeae, N. gonorrhoeae and HIV simultaneously and HIV only.  This graph shows the fold 
change of the expression of the claudin-1 tight junction gene in the ME180 cells infected with N. 
gonorrhoeae, N. gonorrhoeae and HIV simultaneously and HIV only, as compared to the 
uninfected cells, at time points 30 minutes, 6 hours and 24 hours.  A fold change of one implies that 
the expression of the target gene in the infected cells is the same as in the uninfected cells.  
Measurements are the mean values of six to nine experiments and the error bars indicate the SEM.  
The fold change between N. gonorrhoeae only and the uninfected cells was not significantly 
different at 30 minutes (p = 0.09) and 6 hours (p = 0.01) but was significantly different at 24 hours 
(p = 0.008).  The fold change between N. gonorrhoeae and HIV simultaneously and the uninfected 
cells was not significantly different at 30 minutes (p = 0.4) but was significantly difference at 6 
hours (p = 0.008) and 24 hours (p = 0.008).  The fold change between HIV only  and the uninfected 
cells was significantly different at 30 minutes (p = 0.04), 6 hours (0.02) and 24 hours (p = 0.01).  
The statistical analysis was done using a Wilcoxon sign rank test. 
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Fig 4.9  Graph showing fold change of Claudin4 gene expression following exposure to N. 
gonorrhoeae, N. gonorrhoeae and HIV simultaneously and HIV only.  This graph shows the fold 
change of the expression of the claudin4 tight junction gene in the ME180 cells infected with N. 
gonorrhoeae, N. gonorrhoeae and HIV simultaneously and HIV only, as compared to the 
uninfected cells, at time points 30 minutes, 6 hours and 24 hours.  A fold change of one implies that 
the expression of the target gene in the infected cells is the same as in the uninfected cells.  
Measurements are the mean values of six to nine experiments and the error bars indicate the SEM.  
The fold change between N. gonorrhoeae only and the uninfected cells was significantly different at 
30 minutes (p = 0.008) and 24 hours (p = 0.008) but was not significantly different at 6 hours (p = 
0.7).  The fold change between N. gonorrhoeae and HIV simultaneously and the uninfected cells 
was significantly different at 30 minutes (p = 0.008), 6 hours (p = 0.008) and 24 hours (p = 0.008).  
The fold change between HIV only and the uninfected cells was significantly different at 30 
minutes (p = 0.008) and 6 hours (p = 0.02) and 24 hours (p = 0.01).  The statistical analysis was 
done using a Wilcoxon sign rank test. 
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Fig 4.10  Graph showing fold change of Claudin5 gene expression following exposure to N. 
gonorrhoeae, N. gonorrhoeae and HIV simultaneously and HIV only.  This graph shows the fold 
change of the expression of the claudin 5 tight junction gene in theME180 cells infected with N. 
gonorrhoeae, N. gonorrhoeae and HIV simultaneously and HIV only, as compared to the 
uninfected cells, at time points 30 minutes, 6 hours and 24 hours.  A fold change of one implies that 
the expression of the target gene in the infected cells is the same as in the uninfected cells.  
Measurements are the mean values of six to nine experiments and the error bars indicate the SEM. 
The fold change between N. gonorrhoeae only and the uninfected cells was significantly different at 
30 minutes (p = 0.01) and 24 hours (p = 0.01) but was not significantly different at 6 hours (p = 
0.07).  The fold change between N. gonorrhoeae and HIV simultaneously and the uninfected cells 
was significantly different at 30 minutes (p = 0.008), 6 hours (p = 0.008) and 24 hours (p = 0.003).  
The fold change between HIV only  and the uninfected cells was significantly different at 30 
minutes (p = 0.008) and 24 hours (0.02) but not significantly different at 6 hours (p = 0.6).  The 
statistical analysis was done using a Wilcoxon sign rank test. 
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Fig 4.11  Graph showing fold change of the tight junction gene expression following exposure 
to N. gonorrhoeae, N. gonorrhoeae and HIV simultaneously and HIV only.  The graphs show 
the fold change of the expression of the tight junction genes in theME180 cells infected with N. 
gonorrhoeae only (A), N. gonorrhoeae and HIV simultaneously (B) and HIV only (C), as compared 
to the uninfected cells.  A fold change of one implies that the expression of the target gene in the 
infected cells is the same as in the uninfected cells.   
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4.7 Immunofluorescent Staining 
Immunofluorescence staining of occludin was performed as described in section 3.10.  The 
results showed that occludin remained intact with exposure to HIV only, N. gonorrhoeae only 
or a combination of N. gonorrhoeae and HIV at each time point (as shown in Figure 4.12). 
 
 
 
 
 
Fig 4.12  Occludin Immunofluorescence Staining.  The epithelial layer was exposed to HIV 
only, N. gonorrhoeae only or a combination of N. gonorrhoeae at time points 30 minutes, 6 
hours and 24 hours.  Immunofluorescence staining of occludin in the uninfected control can be 
seen for 30 minutes (A), 6 hours (E) and 24 hours (I).  B,F and J shows the immunoflurescence 
staining of occludin following exposure to HIV only at 30 minutes, 6 hours and 24 hours, 
respectively.  C,G and K shows the immunoflurescence staining of occludin following exposure 
to N. gonorrhoeae  only at 30 minutes, 6 hours and 24 hours, respectively.  D, H and L shows 
the immunoflurescence staining of occludin following exposure to N. gonorrhoeae  only at 30 
minutes, 6 hours and 24 hours, respectively.  The occludin remained intact (as indicated by red 
arrows). 
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CHAPTER 5:  DISCUSSION AND CONCLUSION 
 
This study aimed to investigate the effect of N. gonorrhoeae and HIV on the tight junctions of a 
cervical epithelial cell layer to determine whether HIV disrupts the tight junctions of cervical 
epithelial cells, thereby allowing migration of N. gonorrhoeae and HIV across the epithelial layer. 
Such a loosening of tight junctions of mucosal epithelial cells by HIV to facilitate microbial 
translocation was first reported in 2010 by Nazli et al.  An endo-cervical epithelial cell line was 
used since the endocervix is one of the initial sites of infection by N. gonorrhoeae.  A confluent 
epithelial layer with intact tight junctions was established once the transepithelial electrical 
resistance readings reached a steady state.  The formation of a confluent epithelial layer with intact 
tight junctions was further confirmed by ZO-1 immunostaining.  In addition, the permeability of the 
confluent epithelial layer was tested using the blue dextran permeability assay, which showed that 
there was no leakage of the blue dextran dye from the apical to the basolateral media at the time of 
infection.  The effect of N. gonorrhoeae and HIV on the tight junctions of the epithelial layer was 
determined by infecting the epithelial layer with N. gonorrhoeae only, HIV only and a combination 
of N. gonorrhoeae and HIV. 
 
To determine what effect N. gonorrhoeae of different multiplicity of infection (MOI) would have 
on the epithelial layer, the confluent epithelial layer was infected with N. gonorrhoeae at MOI 100, 
10, 1, 0,1 and 0.01, as well as with heat killed N. gonorrhoeae.  At 30 minutes, with a MOI of 100 
and 10, N. gonorrhoeae was able to migrate across the epithelial layer, however the number of 
colonies were too low to count reliably.  This could be due to too many N. gonorrhoeae binding to 
the receptors on the epithelial cells resulting in a decreased migration of the N. gonorrhoeae.  The 
highest migration of N. gonorrhoeae occurred at a MOI of 1.  The MOI of 0.1 and 0.01 did not 
result in migration across the epithelial layer.  At 24 hours post infection, the number of N. 
gonorrhoeae that was present in the basolateral media was similar at MOI of 100, 10, 1 and 0.1.  
The lowest number of migrating microbes was at a MOI of 0.01.  The results show that a MOI of 1 
was an appropriate MOI for the infection assays.  The trans-epithelial migration assay was also 
performed with heat killed N. gonorrhoeae at a MOI of 1.  The heat killed organisms were not 
detected in the basolateral media at 30 minutes and at 24 hours post infection (Figure 4.2).  
However, heat killed N. gonorrheae would not be viable and would therefore not produce colonies 
in the colony-count assay. Therefore, to establish if heat killed N. gonorrhoeae was present in the 
basolateral media, conventional pili protein gene PCR was performed on DNA extracted from the 
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basolateral media.  The results (Figure 4.4) showed that N. gonorrhoeae was not present in the 
basolateral media, which showed that migration of the N. gonorrhoeae is a process that involves 
live bacterial cells.  To establish how N. gonorrhoeae at different MOIs would affect the expression 
of tight junction protein coding genes, the confluent epithelial cell layers were infected with N. 
gonorrhoeae at a MOI of 100, 1, 0.1and 0.01, as well as with heat killed N. gonorrhoeae.  At 30 
minutes and 24 hours post infection, none of the different amountsof N. gonorrhoeae affected the 
tight junction gene expression.   
The N. gonorrhoeae migration assay (section 3.8.1) showed that when the epithelial layer was 
infected with N. gonorrhoeaealone or with N. gonorrhoeae and HIV simultaneously, a small 
percentage of N. gonorrhoeae was able to move across the epithelial layer into the basolateral 
media as early as 30 minutes post infection and continued to move across until at least 16 hours post 
infection.  The percentage of migrated N. gonorrhoeae at 24 hours post infection was found to 
increase above 100% but this was shown to be due to multiplication of the organism in the 
basolateral media. It is likely that the transmigration did not stop at 16 hours. Therefore a 
combination of migration and multiplication must be responsible for the percentage above 100.In 
addition, some multiplication may already have occurred before 16 hrs. At each time point, more 
colony forming units (CFUs) of N. gonorrhoeae were found in the basolateral media when HIV was 
present as compared to when only N. gonorrhoeae was present.  The difference was statistically 
significant at time points, 6 hours (p < 0.05), 16 hours (p < 0.05) and 24 hours (p < 0.05).  The blue 
dextran assay was performed on the epithelial layers at each point of measurement.  The results 
showed that there was no leakage of the blue dextran dye from the apical to the basolateral media at 
any of the points of measurement.  This showed that the tight junctions of the epithelial layers 
remained intact thus preventing the movement of blue dextran through the paracellular pathway.  
Blue dextran has a hydrodynamic diameter of approximately 70nm, whereas N. gonorrhoeae has a 
diameter of 0.6 – 1 µm (Hagel 2011; Morse 1996).  Since the intact epithelial layer prevented the 
movement of blue dextran through the paracellular pathway, it would also have prevented the 
migration of N. gonorrhoeae via the paracellular pathway.  Therefore, N. gonorrhoeae that migrated 
to the basolateral media would have had to use the transcellular pathway.  A study by Rodriguez-
Tirado et al. (2012) showed that even though N. gonorrhoeae did not cause disruption of the tight 
junction proteins ZO-1 or occludin, it was shown to disrupt the adherens junction proteins, E-
cadherin and β-catenin.  They suggested that this possibly resulted in the disruption to the cell 
junction complexes of endometrial and fallopian tube epithelial cells(Rodriguez-Tirado et al. 2012).  
Another study by Edwards et al. (2013) showed that exposure to N. gonorrhoeae resulted in 
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disruption of the tight junction proteins ZO-1 and occludin, as well as the adherens junction 
proteins, E-cadherin and β-cateninin monolayers of endometrial and colorectal cell lines.  Their 
study showed that even though there was disruption to those apical junction proteins, it did not 
affect the paracellular permeability.  Paracellular permeability was determined by the movement of 
Lucifer yellow or fluorescein from the apical media to the basolateral media.  They also showed that 
exposure to N. gonorrhoeae did not affect the movement of Lucifer yellow or fluorescein to the 
basolateral media as compared to the uninfected controls.  Their study therefore suggested that N. 
gonorrhoeae was not able to disrupt the “gate” function which regulates paracellular permeability, 
but it was able to affect the “fence” function of the epithelial cells(V. L. Edwards et al. 2013).A 
study by Wang et al. (2017) showed that N. gonorrhoeae can move to the subepithelium by causing 
the shedding of the columnar epithelial cells.  Their study differed from the here presented study in 
that they used a human cervical tissue explant model and a human colorectal carcinoma cell line. 
 
In the here presented study, the tight junction gene expression assay for the epithelial layers infected 
with N. gonorrhoeae alone or with N. gonorrhoeae and HIV simultaneously, showed a similar 
pattern of expression (Figure 4.11 A and 4.11 B, respectively).  At time points 30 minutes and 6 
hours, the expression of the tight junction genes in the infected cells were expressed similarly to the 
uninfected cells.  At 24 hours post infection, there was a substantial downregulation of claudin 5 
and upregulation of claudin 4 and occludin.  This seemed to occur due to the presence of N. 
gonorrhoeae, since this did not happen with HIV only (Figure 4.11 C).  Although claudin 5 was 
downregulated, it did not seem to affect the integrity of the epithelial layer, as shown by the blue 
dextran permeability assay.  Claudin 5 functions as a molecular sieve preventing the paracellular 
movement of ions smaller than approximately 0.8 kDa(Gunzel and Yu 2013).  Downregulation of 
the claudin 5 gene would therefore not increase the movement of blue dextran and N. gonorrhoeae 
through the paracellular pathway.  Claudin 4 is a pore-sealing claudin and increased expression of 
this claudin results in an increase in the tightness of the epithelial layer (Khan and Asif 2015).  The 
function of occludin is to control the paracellular permeability to small hydrophilic ions.  Therefore 
upregulation of claudin 4 and occludin should increase the tightness of the epithelial layer.  
Immunofluorescence staining of occludin following infection with N. gonorrhoeae alone or with N. 
gonorrhoeae and HIV simultaneously (Figure 4.12) showed that there was no disruption to the 
occludin protein. 
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Some studies have shown that HIV causes disruption to the tight junctions of epithelial layers, 
thereby causing the paracellular space between cells to open, which facilitates the movement of 
other microbes across the epithelial layer (Nazli et al. 2010; Sufiawati and Tugizov 2014).  Nazli et 
al. (2010) demonstrated that exposure of intestinal and primary genital epithelial cells to HIV 
resulted in the downregulation of tight junction genes, as well as in the increased permeability of 
these epithelial layers (Nazli et al. 2010).  Similar findings were reported in a study which showed 
that exposure of oral epithelial cells to HIV caused the disruption of the tight junctions, thereby 
enabling HSV-1 to move across the oral epithelial layer (Sufiawati and Tugizov 2014).  The results 
of this study are in contrast to their findings as it showed that HIV did not affect the permeability of 
the epithelial layer.  The results of the gene expression assay showed that the infection of the 
epithelial layer with HIV (Figure 4.11C) did not affect the tight junction gene expression.  
Furthermore, the blue dextran permeability assay showed that the tight junctions of the epithelial 
layer were intact as the blue dextran was unable to move from the apical to the basolateral media.  
 
The HIV migration assay showed that a small percentage of HIV was able to migrate across the 
epithelial layer to the basolateral side when the epithelial layer was infected with HIV alone or with 
N. gonorrhoeae and HIV simultaneously.  Since blue dextran is smaller than HIV (which is 
approximately 100 nm in diameter), it is highly unlikely that the small percentage of HIV that had 
migrated across the epithelial layer had migrated via the paracellular pathway.  The virus could 
possibly have moved across the epithelial layer via transcytosis.  This is in keeping with other 
studies that have shown that HIV moved across the epithelial layer through transcytosis.  A study by 
Bobardt et al. (2007) demonstrated that cell-free HIV was able to transcytose through primary 
genital epithelial cells.  However, the efficiency of HIV transcytosis was very poor as only less than 
0.02% of the original inoculum passed through (Bobardt et al. 2007).  Similarly, Kinlocket al. 
(2014) showed that HIV-1 was able to transcytose across vaginal epithelial cells using the endocytic 
recycling pathway (Kinlock et al. 2014).  However, their study was performed using cell-associated 
virus.  Hocini and Bomsel (1999) showed that HIV can cross the epithelial cell layer via 
transcytosis of endocytosed HIV.  The study also reported that cell-associated HIV transcytosis 
occurs more efficiently than cell-free virus (Hocini and Bomsel 1999).  Real et al. (2018) 
demonstrated the process of endoctyosis of cell-associated HIV by using live imaging.  They were 
able to show that when HIV infected cells come into contact with the epithelial layer, the HIV 
infected cells cause budding of the HIV towards the epithelium.  The budding HIV is then 
endocytosed by the epithelial cells and is then transported across the epithelial layer, where they are 
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able to infect susceptible cells.  Their study also showed that transcytosis of cell-associated virus 
occurred more efficiently than cell-free virus (Real et al. 2018). 
 
The study by Nazli et al. (2010) was performed on an intestinal cell line and on primary epithelial 
cells that were obtained from the female genital tract.  Interestingly, even though there were 
differences in the results obtained for the gene expression and blue dextran permeability assay for 
the here presented study and the study by Nazli et al. (2010), their HIV translocation assay (which 
was performed on the intestinal cell line) showed that at six hours post HIV infection, less than 0.04 
% of the initial inoculum translocated to the basolateral media and this increased to less than 0.06% 
at 24 hours post HIV infection.  Moreover, there was no bacterial translocation of Escherichia coli 
after infection of the intestinal epithelial cell layer with HIV and E. coli for six hours, while 
exposure of the cell layer to HIV for 24 hours and E. coli for six hours, resulted in approximately 3 
x 10
5
cfu/ml E. coli  translocating to the basolateral media.  Since 1 x 10
8
cfu/ml E. coli was added to 
the apical layer, this implies that approximately 0.3% of the initial inoculum translocated to the 
basolateral media.   It is therefore possible that even though Nazli et al. (2010) was able to show 
disruption to the tight junction gene expression and leakage of the blue dextran dye across the 
epithelial layer, the translocation of HIV and E. coli (which is approximately 0.25 to 1 µm in 
diameter) was not through the paracellular pathway, as the results of the HIV translocation assay is 
similar to the results by Bobardtet al. (2007) and the results of the study presented here.   
 
When considering the bidirectional relationship existing between HIV and “classic” STDs, this 
study adds to a better understanding of the relationship between N. gonorrhoeae and HIV during 
co-infection.  This study suggests that when there is co-infection, N. gonorrhoeae seems to result in 
the HIV moving across the epithelial layer less efficiently, which could mean that other factors may 
be responsible for the increased susceptibility to HIV during co-infection.  This study also shows 
that infection with N. gonorrhoeae only, N. gonorrhoeae and HIV simultaneously and HIV only 
does not disrupt the tight junctions of the epithelial layer, which means that these organisms are not 
disrupting the epithelial layer to expose areas for microbial entry across the epithelial barrier.  In 
addition, the results presented in this study show that N. gonorrhoeae and HIV could possibly move 
across the epithelial layer through transcytosis of the microbes, which means that preventative 
measures could involve targeting the transcytosis of the microbes.  In the absence of other effective 
means to prevent this transcytosis, preventing exposure of the epithelial lining of the female genital 
tract by means of condoms remains the best option. 
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A limitation of this study was that only one isolate of N. gonorrhoeae was used.  Previous clinical 
observations have shown that certain phenotypes of N. gonorrhoeae are more invasive than others 
(Chan and Wiseman 1975).  In addition, the drastic increase in N. gonorrhoeae from time point 6 
hours to 24 hours does not indicate the percentage of N. gonorrhoeae that migrated across the 
epithelial layer during this period as it is unclear at which time point the multiplication of N. 
gonorrhoeae surpassed the N. gonorrhoeae migrating through.  Another limitation of this study was 
that the epithelial layer was not infected with cell-associated HIV.  Therefore, future research 
should involve infecting the epithelial layer with cell-associated virus, infecting the cells using 
different HIV clades, as well as with different pheno- and genotypes of N. gonorrhoeae. 
Furthermore, the limitation of using the transwell model is that even though it provides an idea of 
the in vivo response to pathogens, the model does not mimic all characteristics of human infection. 
 
In conclusion, the results of this study showed that exposure of the cervical epithelial layer to N. 
gonorrhoeae alone, HIV alone or to N. gonorrhoeae and HIV simultaneously did not affect the 
paracellular permeability of the epithelial layer.  The results showed that a small percentage of N. 
gonorrhoeae was able to migrate across the epithelial layer and that the presence of HIV did not 
seem to influence the migration of N. gonorrhoeae.  In addition, a small percentage of HIV was 
able to migrate across the epithelial layer, however the presence of N. gonorrhoeae seemed to cause 
the HIV to pass through the epithelial layer less efficiently than with exposure to HIV only.  The 
overall results suggest that the migration was possibly through transcytosis of the microbes.  The 
overall results from this study therefore does not support the hypothesis that HIV disrupts the tight 
junctions of the epithelial cells, thereby allowing N. gonorrhoeae to move  together with the virus 
across the epithelium by means of the paracellular pathway. 
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CHAPTER 7:APPENDIX 
 
1. Phosphate Buffered Saline (PBS) 
PBS was prepared by dissolving 1 PBS tablet, pH 7.3 (Oxoid, Hampshire, England) in 100 
mL of triple distilled water.  The PBS solution was then autoclaved at 121°C for 15 
minutes.  The solution was then stored at 2 – 8°C. 
 
2.  ME180 Cell Freezing Fluid 
To prepare 50 mL of ME180 cell freezing fluid, 5 mL of dimethyl sulfoxide (DMSO)and 5 
mL of FBS(BioWhittaker, Walkerville, USA) was added to 40 mL of McCoy’s 5A media 
(Gibco, Paisley, United Kingdom).  The solution was filter-sterilised through a 0.22 µm 
filter (Millipore, Burlington, Massachusetts).   
 
3. Enriched GC Agar plates 
To prepare the NYC plates, 18g GC agar base (Oxoid, Hampshire, England) was dissolved 
in 485 ml triple distilled water and the autoclaved at 121°C for 15 minutes.  The solution 
was allowed to cool to 55°C in a waterbath.  Fifteen millilitres of autoclaved water was 
added to a vial of Yeast Autolysate Supplement (Oxoid, Hampshire, England).  When the 
solution had reached 55°C, the Yeast Autolysate Supplement was added and the solution 
was immediately poured into petri dishes.  To prepare 90 mm plates, 20 mL of the solution 
was added to each plate and to prepare 60 mm plates, 10 mL of the solution was added to 
each plate. 
 
4. Brain Heart Infusion (BHI) Broth 
The brain heart infusion broth was prepared by adding 3.7g BHI powder (Oxoid, 
Hampshire, England) and 5g yeast extract (Oxoid, Hampshire, England) to a sterile bottle.  
Triple distilled water was then added to the bottle to obtain a final volume of 100ml.  The 
broth was thoroughly mixed and autoclaved at 121°C for 15 minutes.  When the broth was 
cool, 200 µL of 5% hemin(Sigma, St Louis, USA)and 200 µL of 10% vitamin K(Sigma, St 
Louis, USA)was added. 
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5. 5% Hemin 
Add 2.5mg hemin(Sigma, St Louis, USA) to 1 ml of sodium hydroxide (NaOH), vortex and 
filter-sterilise using a 0.22µm filter (Millipore, Burlington, Massachusetts).  The solution 
was stored at 4 °C. 
 
6. 10% Vitamin K 
Add 5mg vitamin K (Sigma, St Louis, USA) to 1 mL of absolute ethanol, vortex and filter-
sterilise using a 0.22 µm filter (Millipore, Burlington, Massachusetts).  The solution was 
stored at 4°C. 
 
7. N. gonorrhoeae Storage Media 
The storage media was prepared by adding 3.7 g of BHI powder to 80 ml of triple distilled 
water.  The solution was autoclaved at 121 °C for 15 minutes and then allowed to cool.  
Twenty milliliters of filter-sterilised glycerol was added and the media was stored at 4°C. 
 
8. 4% Paraformaldehyde 
Four percent paraformaldehyde was prepared by dissolving 4 g of paraformaldehyde 
powder (Sigma, St Louis, USA) in a final volume of 100 mL of autoclaved water. 
 
9. 0.1% Triton X-100 
To prepare 0.1% Triton X-100, 100 µL of Triton X-100 (Sigma, St Louis, USA) was added 
to 99.9mL of PBS. 
 
10. 3% Bovine Serum Albumin (BSA) 
Three percent BSA was made up by adding 3 g of BSA powder(Sigma, St Louis, USA) to a 
final volume of 100 mL of PBS. 
 
 
 
 
 
 
 
